Regeneron Pharmaceuticals, Inc.: Regeneron Reports First Quarter 2026 Financial and Operating Results

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...

Regeneron Reports First Quarter 2026 Financial and Operating Results

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...
Scientific Research Publishing

Supporting Migrant Parents in Multicultural UK Schools: A Phenomenological Study about Turkish Migrant Parents and Children Perception of School Support ()

This phenomenological study examines perceptions of some migrant Turkish parents and children about support provided by schools for parents. Additionally reveals percept ...
Scientific Research Publishing

Research on the Innovative Path of AIGC Enabling University Basic Course Teaching ()

The development of artificial intelligence-generated content (AIGC) technology brings new opportunities for the teaching reform of basic courses in colleges and universities. Based on the technology ...